Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.

Scope of the Report:

Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The global Viral Inactivation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Viral Inactivation.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Viral Inactivation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Viral Inactivation market by product type and applications/end industries.

Market Segment by Companies, this report covers

Danaher

Merck

Parker Hannifin

Sartorius

SGS

Charles River Laboratories International

Clean Cells

Rad Source Technologies

Texcell

Viral Inactivated Plasma Systems

Wuxi Pharmatech (Cayman)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Kits and Reagents

Services

Viral Inactivation Systems and Accessories

Market Segment by Applications, can be divided into

Blood and Blood Products

Cellular and Gene Therapy Products

Stem Cell Products

Tissue and Tissue Products

Vaccines and Therapeutics

Table of Contents

1 Viral Inactivation Market Overview

1.1 Product Overview and Scope of Viral Inactivation

1.2 Classification of Viral Inactivation by Types

1.2.1 Global Viral Inactivation Revenue Comparison by Types (2017-2023)

1.2.2 Global Viral Inactivation Revenue Market Share by Types in 2017

1.2.3 Kits and Reagents

1.2.4 Services

1.2.5 Viral Inactivation Systems and Accessories

1.3 Global Viral Inactivation Market by Application

1.3.1 Global Viral Inactivation Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Blood and Blood Products

1.3.3 Cellular and Gene Therapy Products

1.3.4 Stem Cell Products

1.3.5 Tissue and Tissue Products

1.3.6 Vaccines and Therapeutics

1.4 Global Viral Inactivation Market by Regions

1.4.1 Global Viral Inactivation Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Viral Inactivation Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Viral Inactivation Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Inactivation Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Viral Inactivation Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Inactivation Status and Prospect (2013-2023)

1.5 Global Market Size of Viral Inactivation (2013-2023)

2 Manufacturers Profiles

2.1 Danaher

2.1.1 Business Overview

2.1.2 Viral Inactivation Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Danaher Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Viral Inactivation Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.3 Parker Hannifin

2.3.1 Business Overview

2.3.2 Viral Inactivation Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Parker Hannifin Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sartorius

2.4.1 Business Overview

2.4.2 Viral Inactivation Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sartorius Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.5 SGS

2.5.1 Business Overview

2.5.2 Viral Inactivation Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 SGS Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.6 Charles River Laboratories International

2.6.1 Business Overview

2.6.2 Viral Inactivation Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Charles River Laboratories International Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.7 Clean Cells

2.7.1 Business Overview

2.7.2 Viral Inactivation Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Clean Cells Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.8 Rad Source Technologies

2.8.1 Business Overview

2.8.2 Viral Inactivation Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Rad Source Technologies Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.9 Texcell

2.9.1 Business Overview

2.9.2 Viral Inactivation Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Texcell Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.10 Viral Inactivated Plasma Systems

2.10.1 Business Overview

2.10.2 Viral Inactivation Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Viral Inactivated Plasma Systems Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

2.11 Wuxi Pharmatech (Cayman)

2.11.1 Business Overview

2.11.2 Viral Inactivation Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Revenue, Gross Margin and Market Share (2016-2017)

3 Global Viral Inactivation Market Competition, by Players

3.1 Global Viral Inactivation Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Viral Inactivation Players Market Share

3.2.2 Top 10 Viral Inactivation Players Market Share

3.3 Market Competition Trend

4 Global Viral Inactivation Market Size by Regions

4.1 Global Viral Inactivation Revenue and Market Share by Regions

4.2 North America Viral Inactivation Revenue and Growth Rate (2013-2018)

4.3 Europe Viral Inactivation Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Viral Inactivation Revenue and Growth Rate (2013-2018)

4.5 South America Viral Inactivation Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Viral Inactivation Revenue and Growth Rate (2013-2018)

5 North America Viral Inactivation Revenue by Countries

5.1 North America Viral Inactivation Revenue by Countries (2013-2018)

5.2 USA Viral Inactivation Revenue and Growth Rate (2013-2018)

5.3 Canada Viral Inactivation Revenue and Growth Rate (2013-2018)

5.4 Mexico Viral Inactivation Revenue and Growth Rate (2013-2018)

6 Europe Viral Inactivation Revenue by Countries

6.1 Europe Viral Inactivation Revenue by Countries (2013-2018)

6.2 Germany Viral Inactivation Revenue and Growth Rate (2013-2018)

6.3 UK Viral Inactivation Revenue and Growth Rate (2013-2018)

6.4 France Viral Inactivation Revenue and Growth Rate (2013-2018)

6.5 Russia Viral Inactivation Revenue and Growth Rate (2013-2018)

6.6 Italy Viral Inactivation Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Viral Inactivation Revenue by Countries

7.1 Asia-Pacific Viral Inactivation Revenue by Countries (2013-2018)

7.2 China Viral Inactivation Revenue and Growth Rate (2013-2018)

7.3 Japan Viral Inactivation Revenue and Growth Rate (2013-2018)

7.4 Korea Viral Inactivation Revenue and Growth Rate (2013-2018)

7.5 India Viral Inactivation Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Viral Inactivation Revenue and Growth Rate (2013-2018)

8 South America Viral Inactivation Revenue by Countries

8.1 South America Viral Inactivation Revenue by Countries (2013-2018)

8.2 Brazil Viral Inactivation Revenue and Growth Rate (2013-2018)

8.3 Argentina Viral Inactivation Revenue and Growth Rate (2013-2018)

8.4 Colombia Viral Inactivation Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Viral Inactivation by Countries

9.1 Middle East and Africa Viral Inactivation Revenue by Countries (2013-2018)

9.2 Saudi Arabia Viral Inactivation Revenue and Growth Rate (2013-2018)

9.3 UAE Viral Inactivation Revenue and Growth Rate (2013-2018)

9.4 Egypt Viral Inactivation Revenue and Growth Rate (2013-2018)

9.5 Nigeria Viral Inactivation Revenue and Growth Rate (2013-2018)

9.6 South Africa Viral Inactivation Revenue and Growth Rate (2013-2018)

10 Global Viral Inactivation Market Segment by Type

10.1 Global Viral Inactivation Revenue and Market Share by Type (2013-2018)

10.2 Global Viral Inactivation Market Forecast by Type (2018-2023)

10.3 Kits and Reagents Revenue Growth Rate (2013-2023)

10.4 Services Revenue Growth Rate (2013-2023)

10.5 Viral Inactivation Systems and Accessories Revenue Growth Rate (2013-2023)

11 Global Viral Inactivation Market Segment by Application

11.1 Global Viral Inactivation Revenue Market Share by Application (2013-2018)

11.2 Viral Inactivation Market Forecast by Application (2018-2023)

11.3 Blood and Blood Products Revenue Growth (2013-2018)

11.4 Cellular and Gene Therapy Products Revenue Growth (2013-2018)

11.5 Stem Cell Products Revenue Growth (2013-2018)

11.6 Tissue and Tissue Products Revenue Growth (2013-2018)

11.7 Vaccines and Therapeutics Revenue Growth (2013-2018)

12 Global Viral Inactivation Market Size Forecast (2018-2023)

12.1 Global Viral Inactivation Market Size Forecast (2018-2023)

12.2 Global Viral Inactivation Market Forecast by Regions (2018-2023)

12.3 North America Viral Inactivation Revenue Market Forecast (2018-2023)

12.4 Europe Viral Inactivation Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Viral Inactivation Revenue Market Forecast (2018-2023)

12.6 South America Viral Inactivation Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Viral Inactivation Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Viral Inactivation Picture

Table Product Specifications of Viral Inactivation

Table Global Viral Inactivation and Revenue (Million USD) Market Split by Product Type<